At present, PSA is the best standard biomarker used for early detection of PC [1–4], although it has only moderate sensitivity (PC may still be present at low levels of PSA) and specificity (benign prostatic hyperplasia or prostatitis may cause false positive results) [1, 2, 5, 6]. Here, KLK3 is linked to male reproductive organ cancer.